Dr. Kontoyiannis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dimitrios P. Kontoyiannis, MD, ScD, PhD (Hon), is the Robert C Hickey Chair in Clinical Care and Deputy Head for Research in the Division of Internal Medicine at The University of Texas MD Anderson Cancer Center. I received my medical degree Summa Cum Laude from the National and Kapodistrian University of Athens, Greece and trained in Internal Medicine at Baylor College of Medicine in Houston, TX, where I served as a Chief Medical Resident. I was subsequently trained as a clinical fellow in Infectious Diseases at Massachusetts General Hospital and obtained a Master in Clinical Sciences from Harvard Medical School in Boston and I spent 3 years at the Whitehead Institute for Biomedical Sciences/Massachusetts Institute of Technology as a fellow in the Harvard MIT Clinical Investigators Training Program. I am considered the leading expert in mycology world-wide (expertscape.com) and among the 1-2 most highly cited investigators in the area of mycology with over 600 peer-reviewed publications and 51000 citations and an H index of 111 (Google Scholar) and in the 1% list of most influential/cited researchers in the biomedical field (Web of Science). I have had a funded laboratory and clinical program in mycology in the last 22 years. I am the recipient of many institutional, national and international awards in research/clinical care, education and mentoring and I am fellow of many honorific societies(see CV). I would be interested to explore relevant and interesting leadership position in Internal Medicine, Infectious Diseases or academia (e.g., Chief of Medicine, Vice Provost, etc) in a prestigious academic center that capitalize of my 22 year multi-faceted and successful experience as a clinical research-oriented faculty at a tertiary care academic center.
Education & Training
- Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1994 - 1998
- Baylor College of MedicineResidency, Internal Medicine, 1991 - 1994
- University of AthensClass of 1989
Certifications & Licensure
- FL State Medical License 2021 - Present
- TX State Medical License 1998 - 2025
- MA State Medical License 1994 - 1999
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 10 citationsNitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for In Vitro Eradication of Candida auris Biofilm.Nylev Vargas-Cruz, Ruth Reitzel, Joel Rosenblatt, Anne-Marie Chaftari, Rita Wilson Dib
Antimicrobial Agents and Chemotherapy. 2019-06-24 - 31 citationsDrosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.Sebastian Wurster, Ashwini Bandi, Nicholas D. Beyda, Nathaniel D. Albert, Nitya M Raman
The Journal of Antimicrobial Chemotherapy. 2019-07-01 - 1444 citationsRevision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study G...J. Peter Donnelly, Sharon C.-A. Chen, Carol A. Kauffman, William J. Steinbach, John W. Baddley
Clinical Infectious Diseases. 2020-09-12
Journal Articles
- Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future DirectionsDimitrios Kontoyiannis, MD, Clinical Infectious Diseases
- Breakthrough Fungal Infections in Patients with Leukemia Receiving IsavuconazoleDimitrios Kontoyiannis, MD, Clinical Infectious Diseases
Press Mentions
- Shop TalkJanuary 5th, 2018
- Shop TalkJanuary 5th, 2018
- Cidara Therapeutics’ Presentations at ASH 2016 to Highlight Potential Role of Novel Antifungal CD101 in Patients with Hematologic MalignanciesNovember 28th, 2016
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: